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Background: ERK5 have distinct signaling roles compared with ERK2.
Results: New crystal structures of ERK5 reveal the structural basis for ERK5 versus ERK2 signaling.
Conclusion: Assembly of the ERK5 signaling cascade requires a unique cooperation between a linear binding motif and a
modular protein-protein interaction domain.
Significance:Molecular principles underlying ERK-specific activation suggest how to interfere with their signaling pathways.
Mitogen-activated protein kinase (MAPK) activation depends
on a linear binding motif found in all MAPK kinases (MKK). In
addition, the PB1 (Phox and Bem1) domain of MKK5 is required
for extracellular signal regulated kinase 5 (ERK5) activation. We
present the crystal structure of ERK5 in complex with an
MKK5 construct comprised of the PB1 domain and the linear
binding motif. We show that ERK5 has distinct protein-pro-
tein interaction surfaces compared with ERK2, which is the
closest ERK5 paralog. The two MAPKs have characteristi-
cally different physiological functions and their distinct pro-
tein-protein interaction surface topography enables them to
bind different sets of activators and substrates. Structural and
biochemical characterization revealed that the MKK5 PB1
domain cooperates with the MAPK binding linear motif to
achieve substrate specific binding, and it also enables co-re-
cruitment of the upstream activating enzyme and the down-
stream substrate into one signaling competent complex.
Studies on present day MAPKs and MKKs hint on the way
protein kinase networks may evolve. In particular, they sug-
gest how paralogous enzymes with similar catalytic proper-
ties could acquire novel signaling roles by merely changing
the way they make physical links to other proteins.
MAPKs are activated through phosphorylation by MAPK
kinases (MKK).2 MKK5 is the specific activator of extracellular
regulated kinase 5 (ERK5), which fulfills non-redundant physi-
ological roles compared with its ERK1/2MAPK paralogs (1–3).
Mammals possess seven MKKs, where MKK1/2, MKK3/6,
MKK7 activate ERK, p38, and JNK, respectively, MKK4 phos-
phorylates both p38 and JNK, andMKK5 activates ERK5 (4–6).
ERK1/2 is generally involved in mediating mitogenic signals,
but ERK5 controls distinct and more specific physiological
responses in neuronal survival and differentiation or in cardio-
vascular development (7–10). Furthermore, ERK5 is the only
critical MAPK required for the maintenance of blood vessel
integrity and vascular homeostasis in the adult (11). ERK2 and
ERK5 are expressed ubiquitously, and their activation patterns
in different tissues may determine physiological outcomes in a
synergistic or combinatorial manner (12, 13).
ERK5 is comprised of an N-terminal MAPK domain homol-
ogous to ERK1/2 and a long non-catalytic C-terminal tail that is
involved in the regulation of its activity and cellular localization
(14, 15). Present day MAPKs have emerged through whole
genome or by individual gene duplication events (16, 17). The
MAPKprotein family arose at the dawn of eukaryotic evolution
and separation of ERK-like and p38-like groups predates the
divergence of animals and fungi (Opisthokonts). The four ani-
mal-specific MAPK subgroups (ERK1/2, ERK5, JNK1/2/3,
p38///) came into existence early in Metazoan evolution.
Interestingly, the ERK5 pathway is intact in all deuterostomes,
but protostomes secondarily lost all components of this signal-
ing pathway. MKKs belong to a separate branch of the kinome
compared with MAPKs (STE7 protein kinase group), and
MKK5 appears to be the closest homolog of ERK1/2 activating
MKKs. Therefore, MKK5, with its unique PB1 (Phox and
Bem1) domain amongMKK enzymes, appeared after the sepa-
ration of MKKs involved in ERK1/2 or p38/JNKMAPK activa-
tion (MKK1/2 versus MKK7/4/3/6, respectively). With the
emergence of vertebrates, full genome duplications created
many similar MAPK and MKK paralogs, but the cladogram of
MAPKs and theirMKK activators, in agreement with their bio-
chemical specificity, concurs well (see Fig. 1A).
Although the three conventional MAPK pathways (ERK1/2,
p38, and JNK) are highly studied, a lot less is known about the
ERK5 pathway. The upstream activators of the three-tiered
MEKK3-MKK5-ERK5 kinase module and its downstream tar-
gets are under intense investigation, particularly because this
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pathway is involved in a number of more aggressive, metastatic
varieties of cancer due to its role in cell survival and prolifera-
tion (3). Growth factor-induced cellular stimulation and oxida-
tive stress activates MEKK2/3, which in turn, activates MKK5
(see Fig. 1B). MEF2 transcription factors are common MAPK
substrates andMEF2A,MEF2Cwere identified as physiological
substrates for ERK5. Thus, in addition to theirmajor regulatory
role in skeletal and cardiac muscle development, these factors
also play an important role in neuronal differentiation and sur-
vival through activation by the ERK5 pathway (18–20). MAPK
substrates, similarly to other MAPK interacting partners such
as MKKs, phosphatases, and protein scaffolds, frequently con-
tain a (D)ocking motif consensus sequence in their unstruc-
tured region (21–23) These D-motifs generally possess a loose
consensus sequence (1–3-X2–5--X-, where , , and X
denote basic, hydrophobic, and any amino acids, respectively),
and they bind to the MAPK docking groove (Fig. 1C) (23–26).
In contrast to other MKK-MAPK systems depending only on
linear D-motifs, efficient activation of ERK5 also requires a PB1
domain located in the N-terminal region of MKK5 (27–29). In
addition, this domain was also shown to play an important role
in MKK5 activation by its MAPK kinase kinase activators,
MEKK2/3 (29, 30).
Here, we investigated the molecular mechanisms determin-
ing the signaling specificity of ERK5 versus ERK1/2 MAPK
modules. These two systems are evolutionarily clearly related;
however, they play distinct physiological roles in mammals.
ERK5, in contrast to ERK2, has a long, non-catalytic C-terminal
tail that is only known to be involved in downstream signaling
events following ERK5 activation (1). Therefore, we focused on
the differences between the ERK2 and ERK5 kinase domains. In
this study, we examined the contribution of the MKK5 PB1
domain and theMKK5 linear docking motif toward ERK5-spe-
cific binding and activation. We determined the crystal struc-
ture of the ERK5 kinase domain alone and in complex with an
MKK5 construct comprised of the MKK5 PB1 domain and the
putativeMAPK binding linearmotif. These revealed that ERK5
and ERK2 docking surfaces are topographically different, sug-
gesting that this is what sets these two MAPKs functionally
apart. We also reconstituted the three-tiered ERK5 MAPK
module (MEKK3-MKK5-ERK5) in vitro and show how the
MKK5 PB1 domain can work as a bivalent adaptor between the
upstream activator kinase and a downstream substrate. These
mechanisms described here for the human ERK5MAPKmod-
ule could have collectively contributed to the emergence of a
distinct ERK-based signaling pathway in most organisms dur-
ing evolution, at least in relation to the better studied andmore
canonical MKK1/2-ERK1/2 system.
EXPERIMENTAL PROCEDURES
DNA Constructs, Protein Expression, and Purification—All
expression constructs were human proteins. Complementary
DNAs (cDNAs) encoding human proteins were produced from
mRNA derived from HEK293 cells. Reverse transcription was
followed by polymerase chain reaction (PCR) with protein-spe-
cific PCR primer pairs. All sequences were verified by DNA
sequencing after subcloning into pET expression vectors. All
experiments were carried out using the ERK5MAPK construct
containing the N-terminal region of ERK5-(1–431) (Uniprot
ID Q13164). This and different MKK5 (Uniprot ID Q13163)
constructs were cloned into amodified pET vector allowing the
expression of recombinant proteins with an N-terminal malt-
ose binding protein (MBP) fusion tag and a C-terminal hexa-
histidine tag. (MKK5 constructs contained the following
regions: A, 1–448; B, 113–448; C, 127–448; D, 166–448; E,
16–130; F:1–112; and G, 113–129). Proteins were expressed in
Esherichia coli Rosetta(DE3) pLysS (Novagen) cells using
standard techniques. Recombinant proteins were purified with
a procedure involving a nickel and/orMBP affinity chromatog-
raphy step that, depending on further use, was followed by an
ion exchange step using a ResourceQ 1ml column (GEHealth-
care). TheMBP tagwas removed by tobacco etch virus protease
cleavage except for MBP pulldown experiments. Final protein
samples were dialyzed into storage buffer containing 20 mM
Tris, pH 8.0, 100 mM NaCl, 10% glycerol, and 2 mM tris(2-car-
boxyethyl)phosphine. All peptides were synthesized on an ABI
431A peptide synthesizer using Fmoc strategy.
Expression and purification of ERK2 was done as earlier
described in Ref. 23. MKK1 and MKK2 constructs were
expressed in E. coliwith N-terminal GST and C-terminal hexa-
histidine tags and double affinity purified with standard proce-
dures. The MEKK3 PB1 domain (residues 42–126) was
expressed as GST fusion protein using a modified pET vector
enabling fusion protein production in bacteria. MEKK3 con-
structs containing the kinase domain were expressed as MBP
fusion proteins in SF9 cells with the Bac-to-Bac baculoviral
expression system (Invitrogen). Proteins were purified from
SF9 cell lysates similarly as described previously for proteins
expressed in E. coli.
Protein-protein Binding Assays—For MBP pulldown experi-
ments, the amylose resin (New England BioLabs) was first
equilibrated with binding buffer (20 mM Tris, 100 mM NaCl,
0.1% octylphenoxypolyethoxyethanol, 2 mM -mercaptoetha-
nol) and 10 g of immobilized MBP fusion protein (and MBP
protein as negative control) was incubated in the presence of 10
M prey in 200l of binding buffer for 30 min at room temper-
ature. Binding reactions typically contained 10–20 l of resin
saturated with baits. Amylose beads were pelleted with centrif-
ugation and washed three times. Retained proteins were eluted
from the resin with SDS loading buffer. Samples were subjected
to SDS-PAGE and stained with Coomassie protein dye. GST
pulldowns were done similarly, but glutathione beads were
used (GE Healthcare).
For fluorescence polarization (FP)-based binding affinity
measurements reporter peptides, pepMKK5 (ASKPPGERNIH-
GLKVNTRA) or pepMEF2 (SRKPDLRVVIPPS) were N-termi-
nally labeled with carboxyfluorescein or tetramethylrhodamin
fluorescent dyes, respectively. PB1-D was labeled with 5-iodo-
acetamidofluorescein (Sigma, I9271) according to the following
procedure: dimethylformamide dissolved dye was added in
5-fold molar excess to purified PB1-D sample that was for-
merly dialyzed in PBS (pH 7.0) and then incubated in the dark
for 2 h at room temperature. Unreacted dye was removed on a
PD-10 buffer exchange column (GE Healthcare). Labeling effi-
ciency was determined to be75%.
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Change in the FP signal in direct binding affinity measure-
ments wasmonitored as a function of increasing concentration
of purified MAPKs with an Analyst GT (Molecular Devices) or
with a Synergy H4 (BioTek Instruments) plate reader in 384-
well plates. The labeled peptides or FP labeled PB1-Dwere at 10
nM in 20 mM Tris, pH 8.0, 100 mM NaCl, 0.05% Brij35P, 2 mM
DTT. The resulting binding isotherms were fit to a quadratic
binding equation with the OriginPro software (version 7,
OriginLab Corp.). The affinity of the unlabeled peptides or dif-
ferent MKK5 constructs to MAPKs was measured in steady-
state competition experiments: 10 nM labeled reporter was
mixedwithMAPK samples in a concentration to achieve60–
80% complex formation. Subsequently, increasing amounts of
unlabeled peptide or protein was added and the FP signal was
FIGURE 1. A PB1 domain in a MAPK kinase is unique to the ERK5 signaling module. A, the cladogram for MAPKs and their specific MKK activators.
Cladograms were calculated based on the sequences of kinase domains for MAPKs or MKKs found in KinBase (57). CDK, cyclin-dependent kinase. (Atypical
MAPKs are ERK3/4/7 or NLK (58), STE11 family is comprised ofMAPK kinase kinases.). B, schematic organization of theMEKK2/3-MKK5-ERK5MAPKmodule. PB1
domains from MEKK3 and MKK5 are shown with colored squares, and a box next to the ERK5 kinase domain indicates the long non-catalytic C-terminal tail
(407–816) of ERK5. C, all MKKs contain a linear D-motif: their sequences are shown for the seven human MKKs. In the MKK D-motif consensus , , and X
denotes basic, hydrophobic, and any amino acids, respectively. In addition, MKK5 also contains an evolutionary conserved PB1 globular domain. The panel on
the right shows theMAPK docking surface colored according to its electrostatic potential (positive in blue and negative in red) from the ERK2 crystal structure
complexedwith a peptide containing theMKK2 linear D-motif (shown in blackwith the side chains of the consensusmotif forming amino acids indicated) (26).
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measured as described earlier for direct titration experiments.
The dissociation constant (Kd) for each MAPK-unlabeled pep-
tide or protein interaction was determined by fitting the data to
a competition binding equation. Titration experiments were
carried out in triplicates and the average FP signal was used for
fitting the data with OriginPro (version 7).
In Vitro Protein Kinase Assays—Reactions were carried out
in 50 mM HEPES, pH 7.5, 100 mM NaCl, 5 mM MgCl2, 0.05%
octylphenoxypolyethoxyethanol, 5% glycerol, 2 mM DTT using
recombinantly expressed and purified proteins in the presence
of 400 M ATP and 5 Ci of [-32P]ATP. Reactions were
stopped with protein loading sample buffer complemented
with 20 mM EDTA, boiled, and then subjected to SDS-PAGE.
Gels were dried before analysis by phosphorimaging or by
Western blots on a Typhoon Trio scanner (GE Healthcare).
Western blots were done by using anti-phospho-ERK5 anti-
body (E7153, Sigma). The constitutive active form of MKK1
(MKK1_EE, S218E/S222E), MKK2 (MKK2_EE, S222E/S226E),
MKK5 (MKK5DD, S311D/T315D) and the kinase inactive ver-
sion of ERK5 (ERK5_KI: D182A), which was used as substrate
in kinase assays, were generated by QuikChange site-directed
mutagenesis or by PCR, and proteins were expressed and puri-
fied as described above. Phosphorylation reporters (MEF2A,
region 269–329; RSK1c, region 411–735, MNK1, full-length,
1–465) were expressed in bacteria as GST fusion proteins with
an N-terminal GST and C-terminal hexahistidine tag and then
double-affinity purified.
Structure Solution of Apo ERK5 and the ERK5PB1-D
Complex—The MAP kinase domain of ERK5-(1–431) and the
MKK5 PB1-D construct (16–130) were expressed as N-termi-
nalMBP fusion proteins with a C-terminal non-cleavable hexa-
histidine tag in E. coli. After double-affinity purification, the
MBP fusion tag was cleaved off by the tobacco etch virus pro-
tease, and samples were further purified by ion-exchange on a
Resource Q column. Purified ERK5 and PB1-D samples were
mixed so that the PB1-Dwould be in excess, and the samplewas
gel-filtrated on a Superdex 75 column (GE Healthcare). Frac-
tions corresponding to the ERK5PB1-D complex were pooled,
and the sample was concentrated to 10 mg/ml.
The stock solution of the final protein sample was supple-
mented with 2 mM adenylyl-imidodiphosphate (AMP-PNP)
and 2 mM MgCl2. Crystallization conditions were found by
using a custom in-house PEG crystallization screen in standard
sitting drop vapor diffusion set-up at 23 °C. ERK5 apo and
ERK5PB1-D complex crystals grew in 35% PEG1000 buffered
with 100 mM sodium citrate (pH 5.0) or in 48% PEG200 buff-
ered with 100 mM MIB (composite buffer of malonate, imida-
zol, and boric acid) (pH 6.5), respectively. Crystals were directly
flash cooled in liquid nitrogen. Data were collected on the PXIII
beam line of the Swiss Light Source (Paul Scherrer Institute,
Villigen, Switzerland).
Datawere processedwithXDS (31). The structurewas solved
bymolecular replacement in PHASER using a startingmodel of
theMKK5PB1 domain (ProteinData Bank code 2O2V) and the
kinase domain from ERK2 (Protein Data Bank code 2Y9Q) (23,
32, 33). The molecular replacement search at 3 Å resolution
identified two ERK5molecules for the apo crystal structure and
two ERK5PB1 complexes for the ERK5PB1-D crystal structure
per asymmetric unit. Structure refinement was carried out in
PHENIX (F 1.35 F), and structure remodeling/building was
done in Coot (34, 35). The final refinedmodels had good geom-
etry, as assessed byMolprobity, with 90.5 and 0.3% of the amino
acid residues in the favored and disallowed regions of the Ram-
achandran plot, respectively (36). X-ray data collection and
structure refinement statistics are given in Table 1. Crystal
structures of apo ERK5 and the ERK5PB1-D complex are
deposited in the Protein Data Bank with identifiers 4IC8 and
4IC7, respectively.
RESULTS
Characterization of the MKK5-ERK5 Interaction—MKK5
contains a C-terminal kinase domain, an N-terminal PB1
domain, and a short linear D-motif located between the former
two domains. We tested the binding of different MKK5 con-
structs to the kinase domain of ERK5-(1–431) in MBP pull-
down experiments. Full-length MKK5 and several deletion
constructs, missing one or two of the regionsmentioned above,
were expressed as MBP fusion proteins in bacteria and then
bound to amylose resin that was incubated with recombinantly
expressed and purified ERK5 (Fig. 2A). These binding studies
showed that neither the PB1 domain nor the MKK5 kinase
domain (MKK5_KD) alonewas sufficient tomediate detectable
binding to ERK5. Interestingly, all constructs that bound ERK5
contained the D-motif in combination with at least one struc-
tured MKK5 domain. These results suggest that multiple
regions in MKK5 synergistically contribute to ERK5 binding.
To assess the contribution of different MKK5 domains
toward MKK5-ERK5 binding quantitatively, we set up a fluo-
rescence polarization based protein-protein interaction assay
for the determination of steady-state binding affinities (Fig. 2B).
The PB1-D MKK5 construct was labeled by 5-iodoacetamido-
fluorescein on a cysteine residue and its complex formation
with ERK5wasmonitored in a FP-based binding assay (Fig. 2B).
This construct boundwith0.5Maffinity to ERK5,whichwas
also confirmed in a competitive titration experiment using
unlabeled PB1-D (Fig. 2B). Next, wemeasured the affinity of the
MKK5-ERK5 interaction using the 5-iodoacetamidofluores-
cein-labeled PB1-D as the reporter and three different MKK5
constructs as the competitor in a competition titration experi-
ment (Fig. 2C). Full-length MKK5 (MKK5_FL) competed with
ERK5PB1-D binding and its binding affinity to ERK5 was
determined to be0.1 M. MKK5_KD, however, did not com-
pete with PB1-D, suggesting that the MKK5 kinase domain
contacts ERK5 on a surface that is not used in the ERK5PB1-D
complex. In contrast, MKK5_PB1 did compete; however, its
titration curve could not be fit to a simple competition binding
equation. This shows that competition with the ERK5-PB1-D
interaction by the D-motif inMKK5_PB1 does not confer to a
simple one-site binding model: the binding of the PB1 domain
and the D-motif to ERK5 may be synergistic for example.
Results of these quantitative measurements are consistent with
the results ofMBP pulldown experiments. They suggest that all
three regions of MKK5, the PB1 domain, the D-motif, and the
kinase domain, contact ERK5 on complementary surfaces (Fig.
2D). All contacts seem to contribute to the high affinity (100
nM) of the MKK5ERK5 complex.
Specific Activation of ERK5
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Crystal Structure of the ERK5PB1-D Complex—To gain
insight into the structural basis of MKK5-ERK5 binding, we
determined the crystal structure of the ERK5 kinase domain
bound to an MKK5 construct that mediated submicromolar
binding and contained both the PB1domain aswell as the linear
D-motif (PB1-D) (Fig. 3A). The PB1-D construct contacts the
MAPK on two distinct surfaces: the linear motif binds in the
MAPKdocking groove (IF1), whereas the PB1 domain interacts
with ERK5 on the N-terminal kinase lobe (IF2). Overall, this
complex displays 1600Å2 buried surface area. The final crystal-
lographic model of the ERK5PB1-D complex contains two
complexes in the asymmetric unit related by non-crystallo-
FIGURE 2.Characterization of theMKK5-ERK5 interaction.A, three distinctMKK5 regions contribute to its interactionwith ERK5.MBP pulldown results with
the ERK5 kinase domain (residues 1–431) as prey and different deletion constructs (A, A–G panels) of MKK5 as baits. Interaction of bait and prey was detected
on an SDS-PAGE gel stainedwith Coomassie protein dye. Arrows indicate the position of ERK5 in the pulldown experiments. MBP control was used as negative
control to assess unspecific binding of the prey. Bands appearing in addition to baits or preys are degradation products of MBP-fusion proteins. The panel
shows the results of a representative MBP pulldown assay from two independent experiments. B, schematic diagram of direct (top panels) and competitive
(bottom panels) FP-based titration experiments for determining protein-peptide or protein-protein binding affinities (Kd). Panels on the right show binding
isotherms for direct (on the top) and for competitive (on the bottom) ERK5PB1-D binding experiments. Errors indicate uncertainty in the fit, and error bars on
the binding isotherms show S.D. based on three independent measurements. C, competitive binding experiments to monitor binding of MKK5_KD,
MKK5_PB1, andMKK5_FL toERK5. Thepanel shows thecompetitivebindingcurveusingunlabeledPB1-Das thecompetitor and labeledERK5PB1-Dcomplex
as the reporter (PB1-D labeled with 5-iodoacetamidofluorescein, IAF). The y axis shows the degree of complex formation that was determined based on
arbitrary FPmin and FPmax units from numerical fits to competitive binding equations as shown on B. Data were fit to a competition binding equation. Errors
indicateuncertainty in the fit, and error barson thebinding isotherms showS.D. basedon three independentmeasurements.D, interactions contributing to the
formation of the MKK5ERK5 binary complex: (i) the MKK5 PB1 domain binds to the ERK5 kinase domain, (ii) MKK5 D-motif presumably binds in the ERK5
dockinggroove, and (iii) theMKK5 kinasedomainbinds to the ERK5 kinasedomainon an areadistinct from thePB1 andD-motif-interacting surfaces. This latter
interactionmight speculatively formbetween theMKK5 active site and the ERK5 activation loop (shownwith anasteriskorwith ablack line, respectively). conc.,
concentration.
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graphic symmetry. The two complexes are greatly similar
(r.m.s.d. is 1.0 Å for 451 C atoms), and the only difference
between the two complexes appears to be that the C-terminal
region of the PB1-D construct is less structured in one of the
complexes. In addition, we also determined the crystal struc-
ture of the ERK5 kinase domain without its interaction partner
(apo ERK5). This crystallographic model also contains two
ERK5 molecules related by non-crystallographic symmetry
(Table 1). The two ERK5 molecules are also highly similar
(r.m.s.d. of 0.6 Å for 324 C atoms); however, a short region
(150–155) corresponding to an important part of the MAPK
docking groove is disordered in one of the ERK5molecules (see
below).
The ERK5PB1-D complex crystal structure demonstrates
how the MKK5 PB1 domain and the D-motif contacts ERK5.
The N-terminal part of the MKK5 D-motif unexpectedly does
FIGURE 3.Crystal structureof theERK5PB1-D complex.A, transparent surface representationof the ERK5PB1-D complex. The ERK5 kinase domain is shown
in gray, and its C-terminal region (from 385 to 399) is shown in red. The MKK5 PB1-D construct is shown in orange. B, zoomed-in view of the protein-protein
interface in theMAPKdocking groove (IF1). C, zoomed-in viewof the protein-protein interface on the PB1 domain (IF2). Only amino acid side chains appearing
toplay an important role at the interfaces are indicated. Specific hydrogenbondsare shownwithdashed lines, and thenon-hydrolyzableATPanalog,AMP-PNP,
is shown in pink.D, representative examples of electron density maps shown around theMKK5 D-motif at IF1 and the ERK5 C-terminal extension at IF2. 2Fo
Fcmapswere calculatedwith the ERK5PB1-D final model and contoured at 1. E, results of binding affinitymeasurements on ERK5PB1-D complex formation.
The table displays the binding affinities between wild-type (see also Fig. 2B) or modified versions of MKK5 PB1-D and ERK5 kinase domain constructs.
ERK5C385–399 lacks the C-terminal ERK5 kinase domain region shown in red on A and C. PB1-Dmut is an MKK5 PB1-D construct in which Arg-115, Leu-120,
and Ile-122 are mutated to alanines. ( indicates no detectable binding; Kd  100 M). Errors indicate uncertainty in the fit, and error bars on the binding
isotherms show S.D. based on three independent measurements.mut, mutant.
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not engage Arg-115 in binding the aspartate residues of the
commondocking site (Asp-352 andAsp-355) (Fig. 1C) (28). It is
Lys-110 that contacts Asp-352 from ERK5, and the intervening
region between this basic amino acid and the hydrophobic
motif (Leu-120 and Leu-122) adopts an L-shaped turn stabi-
lized by side chain-specific hydrogen bonds (Arg-115 and Asn-
116) and by a short polyproline type II helix (Pro-111, Pro-112,
and Gly-113) (Fig. 3, B and D). Leu-120 and Leu-122 from
PB1-D bind into the classical xMAPK docking groove sim-
ilarly to other MAPK binding linear motifs (23). At the other
ERK5PB1-D interface, theC-terminalMAPK region (from res-
idue 385 to 399) makes several main chain atom mediated
hydrogen bonds to residues of a -strand (between residue 26
and 32) from the PB1 domain (Fig. 3, C and D). These side
chain-independent interactions are complemented by side
chain-mediated hydrogen bonds formed by Arg-391 and Arg-
392 from ERK5. Importance of contacts observed by the ERK5
MAPK docking groove (IF1) or by the novel interface on the
MKK5 PB1 domain (IF2) was confirmed by fluorescence polar-
ization-based protein-protein binding assays. Although the
ERK5 MAPK construct bound PB1-D with 0.5 M affinity,
there was no interaction detected between two modified con-
structs where the D-motif and the C-terminal ERK5 kinase
domain extension both were mutated or deleted, respectively
(Fig. 3E). The PB1-Dmut construct contained alanine replace-
ments at Arg-115, Leu-120, and Leu-122; ERK5C385–399
lacked its PB1 domain interacting region. These also bound
their corresponding wild-type partner with greatly reduced
(50-fold or 20-fold) binding affinities (Fig. 3E). These results
demonstrate how theMKK5 PB1 domain and anMKKdocking
motif forms synergistic contacts and how MKK5 engages
canonical as well as novel protein-protein interaction surfaces
to mediate high affinity binding to ERK5.
Distinct Protein Interactions of ERK5 and ERK2—Binding
affinity measurements showed that although PB1-D bound
ERK5 with submicromolar affinity, ERK2 did not bind to the
same MKK5 construct (Fig. 4, A and B). Similarly, the linear
D-motif fromMKK5 bound only to ERK5 but not to ERK2 (Fig.
4, A, D, and E). These findings are in line with the observation
that MKK5 could not phosphorylate ERK2 in cell-based assays
(28). ERK5 stimulates the activity of MEF2 transcription fac-
tors; it binds to theD-motif inMEF2A/C, and it promotes phos-
phorylation of criticalMAPK regulatory target sites (37).More-
over, it was shown earlier that a D-motif containing peptide
from MEF2A binds to ERK2 and p38 (23, 24). We tested the
binding of a labeled MEF2A peptide (pepMEF2) to ERK5 and
found that this linearmotif containing peptide indeed bound to
ERK5 as expected (Fig. 4C). We also tested the binding speci-
ficity of ERK5 to other ERK2 binding D-motifs derived from
known ERK2 interaction partners. Of five additional linear
motifs, it was only the RSK1 peptide that mediated modest
binding to ERK5 (Fig. 4A,D) (38). These suggest that ERK5 can
discriminate against canonical ERK2 partners via its docking
groove. Conversely, short linear motifs can contribute to bio-
logically relevant MAPK-partner protein binding specificity.
They may be ERK2- or ERK5-specific, or nondiscriminatory.
Moreover, binding specificity of MKK linear motifs showed
agreement with the in vitro phosphorylation pattern of MKK-
MAPK pairs when theMAPK phosphorylation capacity of con-
stitutively activated forms of MKK1, MKK2, and MKK5 were
tested: MKK1/2 phosphorylated only ERK2 and MKK5 phos-
phorylated only ERK5 (Fig. 4F). We also tested the substrate
phosphorylation profile of preactivatedMAPKs using three dif-
ferent substrate proteins (MEF2A, RSK1, and MNK1) (23).
Similarly to the ERK2 and ERK5 phosphorylation experiments
byMKKs described above, the goal of these experiments was to
test how linear docking motifs mediate binding and activation
of longer protein constructs or full-length proteins. The MEF2
phosphorylation reporter contained a 50-amino acid-long
region of MEF2A containing the region spanning from the
D-motif to the MAPK target sites (Thr-312 and Thr-319) (23),
the RSK1 construct contained the C-terminal RSK1 kinase
TABLE 1
Crystal structure solution and refinement of apo ERK5 and the ERK5PB1-D complex
Apo ERK5 ERK5PB1-D
Data collection
Space group P21 P43
Cell dimensions a	 59.9, b	 93.2, and c	 69.3 Å; 	 90.0, 	 89.9,
and 	 90.0°
a	 69.4, b	 69.4, and c	 271.2 Å; 	 90.0, 	 90.0,
and 	 90.0°
Resolution (Å)a 45.29–2.8 (2.87–2.8) 48.27–2.6 (2.67–2.6)
Rmergea 0.057 (0.459) 0.051 (0.719)
I/(I)a 17.46 (2.69) 19.03 (2.52)
Completeness (%)a 98.1 (100.0) 99.8 (98.6)
Redundancya 3.5 (3.3) 4.5 (4.5)
Refinement












Bond lengths (Å) 0.006 0.008
Bond angles 1.52° 1.59°
a Values in parentheses are for the highest resolution shell.
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domain in addition to the RSK1 docking motif (RSK1c) (23),
and the MNK1 construct was full-length. Preactivated wild-
type ERK2 and ERK5 kinase domain with constitutively acti-
vated forms of MKK1 (MKK1_EE) and MKK5 (MKK5_DD),
respectively, phosphorylated these substrates with a specificity
profile that showed agreement with their linear motif binding
FIGURE 4. Specificity of the ERK5 MAPK docking groove compared with ERK2. A, ERK5 and ERK2 binding affinities of chemically synthesized peptides
comparedwith the binding affinities of theMKK5 PB1-D construct. Asterisks indicate peptides for which ERK2 binding affinities are listed from Ref. 23. Aminus
sign indicates no detectable binding; Kd 100M. Amino acids corresponding to the xmotif are shown in boldface type, and basic amino acids binding to
the negatively charged common docking (CD) groove are underlined and shown in boldface type. Note that linear motifs may bind into the MAPK docking
groove in twodifferentN-to-C-terminal orientations. In addition to the classical D-motif, reverseD-motifs also exist (e.g.pepMNK1or pepRSK1) (23). Shownare
the results of PB1-D (B) and MEF2A (C) docking peptide binding experiments with ERK5 and ERK2, ERK5 competitive titration experiments with various
chemically synthesized peptides (D), ERK2 binding experimentwith pepMKK5 (E). Errors indicate uncertainty in the fit, and error bars on the binding isotherms
showS.D. basedon three independentmeasurements. F,MKK1,MKK2, andMKK5phosphorylateonly their cognateMAPK in vitro. Recombinant ERK5andERK2
(5M)were incubated as substrateswith constitutively activated formsofMKKenzymes (MKK1_EE,MKK2_EE,MKK5_DD; 0.5M) in thepresence of radioactive
[-32P]ATP.G, phosphorylationof differentMAPK substrates by ERK5 andERK2. Recombinantly expressedwild-typeMAPKs (1M)werepreincubatedwithATP
and constitutively active MKK5 or MKK1 enzymes (1–1M) creating activatedMAPKs (*), in turn phosphorylation of MEF2A, MNK1, and RSK1 phosphorylation
reporters wasmonitored by adding 5-fold excess of substrates (5M) in the presence of radioactive [-32P]ATP. F andG show typical phosphorimaging results
of in vitro kinase assays from two independent experiments.
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profile determined with short peptides (Fig. 4G). These results
suggest that short linear motifs contribute to biologically rele-
vant MAPK activation or MAPK substrate phosphorylation
profiles also in the context of their full protein sequence.
Different Sequence and Surface Features on ERK5 and ERK2—
ERK2 and the ERK5 kinase domains are 50% identical and
80% similar in sequence (Fig. 5A). Moreover, the D-motif-
bound kinase domains of these two MAPKs superimpose well
(with average r.m.s.d. of 1.0 Å for 240 C atoms). What is the
structural basis for the distinct interaction partner selection for
ERK5 compared with ERK2? Interestingly, the x groove of
the MAPK docking groove greatly differs in the apo ERK5 and
Specific Activation of ERK5
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in the ERK5PB1-D complex crystal structures (Fig. 5, B–D). A
loop region forming the base of this hydrophobicMAPKgroove
changes its conformation upon binding the MKK5 D-motif
(Fig. 5, E and F). This region lies between residues 145 and 153
and is directly involved in mediating protein-protein interac-
tions as observed in the ERK5PB1-D complex (IF1). Interest-
ingly, the corresponding loop region is well ordered in all apo
ERK2 structures and, in contrast to ERK5, it does not show any
conformational change upon D-motif peptide binding (23,
39–42). A conserved glutamine in all classical MAPKs (Gln-
152 in ERK5 and Gln-119 in ERK2) plays an important role in
D-motif binding at this region (referred to as the Q loop hence-
forth). This conserved residue mediates hydrogen bonding
interaction with the backbone amide or carbonyl group of the
amino acid located between the A and B positions of the
D-motif consensus. As shown on Fig. 5, B–D, the width of this
pivotalD-motif binding region, andultimately its overall topog-
raphy, are determined by the position of the conserved gluta-
mine residue and amino acids located in the so-called specific-
ity loop (Glu-192 and Asn-193 in ERK5) (23). The Q loop
appears to be supported and held in place for H-bonding with
the D-motif by a network of hydrogen bonds around Arg-258
(Fig. 5F).
Furthermore, the Q loop, the specificity loop, as well as the
residue corresponding to Arg-258 in ERK5 or to Asn-224 in
ERK2 are evolutionarily conserved withinmembers of a certain
MAPK group (ERK1/2, ERK5, p38, and JNKs); however, they
are distinct across members belonging to different MAPK
groups (Fig. 5, B and C). For example, the Q loop is longer by
one amino acid in all known and annotated ERK5 orthologs
compared with ERK2 orthologs. Furthermore, the Q-loop has
different amino acid composition in the two MAPKs, resulting
in different flexibility and protein-protein interaction surface
topography. Moreover, ERK5 has a short C-terminal kinase
domain extension, which is involved in MKK5 PB1 domain
binding and is unique among all MAPKs. These differences
between ERK2 and ERK5 in turn form the basis for their differ-
ential protein-protein interaction capacity.
The MKK5 PB1 Domain Organizes MEKK3, MKK5, and
ERK5 into One Signaling Competent Complex—Formerly, the
MKK5 PB1 domain was shown to mediate MEKK3 binding via
PB1 domain-mediated heterodimerization (27, 30). Here, we
set up an in vitro kinase assay to monitor MEKK33MKK53
ERK5 activation with recombinantly expressed and purified
ERK5 MAPK module components. The ERK5 MAPK module
was reconstituted in vitro, and ERK5 phosphorylation was
monitored by anti-phospho-ERK5 Western blots upon addi-
tion of full-lengthMKK5, full-lengthMEKK3, or aMEKK3 con-
struct lacking theMEKK3 PB1 domain but containing an intact
kinase domain (MEKK3_KD, 354–626) (Fig. 6A). We detected
efficient ERK5 phosphorylation only with full-length MEKK3
but not with theMEKK3_KD construct that lacked theMEKK3
PB1 domain. The inability of MEKK3_KD to phosphorylate
ERK5, however, was not due to its lack of kinase activity because
thisMEKK3 construct phosphorylated a general protein kinase
substrate (myelein basic protein) as efficiently as full-length
MEKK3 (Fig. 6A).
Next, we tested whether the MKK5 PB1 domain may simul-
taneously bind to its upstream activator, MEKK3, as well as to
its downstream substrate, ERK5. Results of GST pulldown
experiments showed that ERK5 could be recruited to the
MEKK3 PB1 domain (used as baits in this experiment) only
via the MKK5 PB1-D construct (Fig. 6B). In addition, fluo-
rescence polarization-based protein-protein binding assay
with labeled PB1-D and ERK5 showed that binding between
the MKK5 PB1 domain and ERK5 cannot be competed off by
a MEKK3 PB1 domain construct (Fig. 6B). These suggest
that MKK5 PB1 domain can serve as an adaptor between
MEKK3 and ERK5.
As a summary, Fig. 6C schematically depicts a signaling com-
petent complex of theMEKK3-MKK5-ERK5MAPKmodule. It
highlights the different molecular mechanisms through
which the unique PB1 domain in MKK5, which is not found
in other MKKs, contributes to ERK5-specific activation.
These include synergism with a linear D-motif to mediate
ERK5-specific binding and adapter/scaffold function for the
recruitment of the MAPK kinase kinase activator and the
MAPK substrate.
DISCUSSION
D-motifs are simple protein-protein interactions tools that
MAPKs use to make connections to their partner proteins.
These short linear motifs (7 to 17 amino acids) were shown to
be able to efficiently discriminate JNK MAPKs from ERK1/2
and p38 MAPKs because JNK has an evolutionary remodeled
docking groove compared withmore ancient ERK/p38 kinases.
(Namely, JNK has a narrowed docking groove that can be
bound only by D-motifs with a shorter intervening region
between  and  positions) (23).) Most D-motifs cannot spe-
cifically target the topographically more similar ERK2 and p38
docking grooves, and additional factors contribute in determin-
ing the signaling specificity of ERK1/2- and p38 MAPK-based
FIGURE 5. Different sequence and surface features set ERK5 apart from ERK2. A, sequence alignment of the ERK5 kinase domain and full-length human
ERK2. Sequence regions that are important and responsible for different ERK5 versus ERK2 protein-protein binding surface topography are highlighted in red.
The threonine and tyrosine phosphorylation target sites of the upstream kinase, which are located in the MAPK activation loop, are shown in boldface type. B,
comparison of the xMAPK docking groove region from apo ERK5 and the ERK5MKK5(PB1-D) complex. Note that the conformation of the Q-loop (shown
between two small arrows) differs between the apo (red) and the complexed (gray) crystal structures. (This panel shows the conformation of the ERK5 Q loop
from one of the non-crystallographic symmetry-related ERK5 molecules, whereas this region is disordered in the other molecule.) C, comparison of the x
MAPK docking groove region from the ERK5MKK5(PB1-D) and the ERK2-pepMKK2 complex crystal structures (26). Note the difference in thewidth of thex
binding groove. The width is defined by the distance between two H-bond forming amino acids from theMAPK specificity loop on top and from the so-called
Q loop from below. These twoH-bonds are observed in all knownMAPK-docking peptide complex structures, and they are shownwith dashed lines. Sequence
logosonB andC show theevolutionarily conservedbutdistinct ERK2andERK5Q-loop sequences (fromvarious annotated vertebrate, primitivemetazoan, and
opisthokont MAPKs.) D, superposition of the ERK5MKK5(PB1-D) and the ERK2-pepMKK2 complexes. The figure shows the C trace of the two MAPKs when
they bind to MKK5 or MKK2 constructs. Note the different width of the MAPK docking groove, which is set by the amino acid supporting the Q loop (Arg-258
in ERK5 and Asn-224 in ERK2). E, 2Fo Fc electron density map contoured at 1 and shown around the Q loop from apo ERK5. F, 2Fo Fc maps contoured at
1 and shown around the Q loop (left) or around Arg-258 (right) from the ERK5PB1-D complex. Dashed lines show H-bonds.
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systems. For example, theMKK1/2 and theMKK6D-motif can
bind to cognate and non-cognate MAPKs as well. However,
these MKK enzymes can phosphorylate their cognate MAPK
only. This is because the MAPK activation loop sequence,
which serves as the substrate forMKK enzymes, is highly diver-
gent for ERK1/2 and p38 kinases. For the ERK1/2 and ERK5
system, a similar mechanism is not likely to play an important
role. First, the activation loop sequence of these MAPKs are
very similar, and second, it was shown earlier that if the MKK1
catalytic domain is artificially recruited to ERK5, it can activate
this noncognate MAPK (29). In this study, we examined the
specificity of protein-protein interactions underpinning ERK5
versus ERK1/2 signaling.
Results of binding affinity measurements with some chemi-
cally synthesized peptides containing linear D-motif sequences
showed that these bound with biologically relevant specificity
to ERK5 or ERK2. For ERK5, however, a longer MKK5 con-
struct containing the PB1 domain in addition to its D-motif
bound its cognate MAPK with an order of magnitude stronger
(Kd	 4.2 M versus Kd	 0.4 M). Interestingly, similar exam-
ples for synergism between a MAPK docking groove binding
D-motif and other linear motifs, microdomains, or domains
have already beendescribed (43–47). In these examples,MAPK
protein partners may use both docking motifs and structured
domains simultaneously, where these function together to
enable high binding affinity or novel MAPK interaction speci-
ficity. In the MAPK-responsive ATF2 transcription factor, for
example, both its D-motif as well as the Zn finger directly pre-
ceding it in its regulatory region needs to be intact, and they
appear to be synergistic in mediating binding between JNK and
ATF2 (48, 49). The topography of the linear D-motif binding
docking groove of most MAPKs is similar. Thus, for signaling
networks relying on the use of linear binding motifs to govern
their protein-protein interaction specificity, it is vital to use
FIGURE 6. TheMKK5PB1domain serves as an adaptor betweenMEKK3 and ERK5.A, results of in vitro reconstituted kinase assayswithMEKK3-MKK5-ERK5
kinase module components (0.1 M MEKK3, 0.2 M MKK5, and 2 M ERK5). ERK5 phosphorylation was detected by anti-phospho-ERK5 Western blots. Panels
show the phosphorimaging results of kinase activity experiments on a general kinase substrate. MEKK3_FL, full-length; MEKK3_KD, kinase domain; MyBP,
myelin basic protein. Panels show a representative set of results from two independent experiments. B, ERK5 kinase domain, PB1-D fromMKK5, and the PB1
domain fromMEKK3 form a ternary complex. Results of a GST pulldown experiment, with GST-MEKK3(PB1) as the bait and the ERK5MAPK domain and aMBP
fusionofMKK5(PB1-D) asprey, are shown in the SDS-PAGEgel stainedwithCoomassieproteindye (top). Lanes 1 and 2 corresponding toprey show theposition
of ERK5andMBP-PB1-Dproteins. Control lanes (lanes 3and4) indicate the lackof unspecific binding toGSTprotein-loadedglutathionebeads. Thepanel shows
the results of a representativeGSTpulldownassay from two independent experiments. Thepanel belowshows the results of a fluorescencepolarization-based
binding assay where complex formation between ERK5 and a labeled MKK5 PB1-D construct was attempted to be competed by the addition of increasing
amounts of GST-MEKK3(PB1). Error bars on the binding isotherms show S.D. based on three independent measurements. Results of this experiment are also
consistent with the existence of a ternary ERK5PB1-DMEKK3(PB1) complex. C, role of PB1 domains in ERK5 activation: (i) synergism between the linear MKK5
D-motif and the MKK5 PB1 domain contributes to high affinity MAPK specific binding (ii) adapter/scaffold function of the MKK5 PB1 domain ensures efficient
phosphorylation of ERK5 initiated by MEKK3. An asterisk indicates kinase active sites. P in red highlights ERK5 activation through activation loop phosphor-
ylationbyMKK5.D,model of the ERK5PB1-DMEKK3(PB1) ternary complex (shown in surface representation). Thebinary complex crystal structure of theMKK5
and MKK3 PB1 domains (Protein Data Bank code 2O2V) was superimposed on the ERK5PB1-D complex via the MKK5 PB1 domain.
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mechanisms based on positive and/or negative selection (50,
51). We showed that the linear D-motifs from MKK1 and
MKK2 could not bind to the evolutionarily modified ERK5
docking groove as an example for negative selection. Con-
versely, theMKK5PB1 domain increased the binding affinity of
the MKK5 D-motif as an example for positive selection. The
sequence of ERK1/2 and ERK5 activation loops are identical
around the MKK target sites. Furthermore, it was previously
demonstrated that an MKK5(PB1-D)-MKK1 chimera, where
the first 131 amino acids of MKK5 was fused to full-length
MKK1, can efficiently phosphorylate and activate ERK5 in cell-
based assays (29). These suggest that signaling specificity in
these evolutionarily related two MKK-MAPK systems is not
based on different catalytic properties but is rather determined
by the distinct protein-protein recruitment capacity of their
components.
PB1 domains are compact modular protein-protein interac-
tion domains comprised of less than 100 amino acids: they
mediate homo- and heterodimerization between diverse pro-
teins (30, 52). TheMKK5 PB1 domain did indeed bind to ERK5
in addition to binding to theMEKK3PB1 domain. Recently, the
crystal structure of the MKK5 PB1/MEKK3 PB1 domain het-
erodimer was determined by x-ray crystallography (Protein
Data Bank code 2O2V) and the MKK5 PB1 domain binding
surface on the MEKK3 PB1 domain was studied by NMR (30).
When the heterodimer of theMEKK3 andMKK5 PB1 domains
is superimposed on the binary ERK5PB1-D complex through
their common MKK5 PB1 domains (489 atoms, r.m.s.d. of 0.7
Å), the MEKK3 PB1 domain shows no sterical clash with ERK5
in theMEKK3PB1MKK5PB1-DERK5 ternary complexmodel
(Fig. 6D). This is in agreement with the results of our protein-
protein association studies on this ternary complex. Thus, the
MKK5 PB1 domain seems to function as an adaptor: it engages
two distinct surfaces to bind MEKK3 and ERK5, and it assem-
bles the MEKK2/3-MKK5-ERK5 module into one signaling
competent complex (29, 53).
MKK5 is the specific activator of ERK5, which fulfills non-
redundant physiological roles compared with its ERK1/2 para-
logs. Present dayMAPKs have emerged throughwhole genome
or by individual gene duplication events during evolution (16).
After gene duplication events, a new paralog may distinguish
itself by forming new connections with proteins from other
signaling circuits (54). For example, JNK3 sets itself apart from
the other two JNK paralogs by possessing a unique40-amino
acid-long N-terminal extension to its kinase domain. This
enables JNK3 to be specifically recruited to and to be activated
by the -arrestin2 scaffold complex (55). Interestingly, two cla-
dograms drawn based on available present day MAPK and
MKK sequences concur well (Fig. 1A). MKK-MAPK signaling
thus serve as an excellent paradigm how protein-protein inter-
action elements, structurally and functionally unrelated, may
come together to determine signaling specificity during the
evolution of paralogous signaling enzymes. Our results on the
MKK5-ERK5 system particularly demonstrates how a C-termi-
nal extension to the MAPK domain and the acquisition of a
dedicated protein-protein interaction tool in theMKK enzyme
(i.e. a PB1 domain) may have enabled a new MKK-MAPK pair
to distinguish itself from itsMKK1/2-ERK1/2 homologs (56). In
addition, we also demonstrated that the topography of the
MAPK docking groove is different among related present-day
MAPKs. Naturally, this also contributes to the differential
partner protein preferences of ERK2 and ERK5. The charac-
terized signaling relevant protein-protein interactions of
MKK5ERK5 andMKK1/2ERK1/2 complexes show how sig-
naling enzymes with common origin could acquire novel
protein-protein interaction profiles. This is a pivotal step
that ultimately could lead to the emergence of distinct sig-
naling pathways.
Finally, our results provide structural insight into how pro-
tein-protein interaction specificity is determined for closely
related but functionally distinct MAPK-based systems. This
knowledge will be a great asset for interfering with ERK1/2- or
ERK5-based pathways in a targeted fashion.
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